Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2)
- 1 January 1997
- journal article
- research article
- Published by Wiley in Radiation Oncology Investigations
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Fractionation in radiotherapyCancer Treatment Reviews, 1994
- Antitumor effect of locally injected low doses of recombinant human interleukin-2 in bovine vulval papilloma and carcinomaVeterinary Immunology and Immunopathology, 1994
- Phase Ib Trial of the Effect of Peritumoral and Intranodal Injections of Interleukin-2 in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck: An Eastern Cooperative Oncology Group TrialJournal of Immunotherapy, 1994
- Clinical and immunological effect of intravesical interleukin-2 on superficial bladder cancerCancer Immunology, Immunotherapy, 1994
- Tumour necrosis factor and cancerProgress in Growth Factor Research, 1992
- A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma.Journal of Clinical Oncology, 1991
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Principles of Fractionation in RadiotherapyPublished by Springer Science and Business Media LLC ,1988
- Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipientsCancer Immunology, Immunotherapy, 1983